Clinical Trial

Inflammatory Indices, Early Mortality, and ICU Stay in Geriatric PFN Patients

Study acronym: PFN-RAR
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This retrospective observational cohort study aims to evaluate the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing proximal femoral nailing (PFN) for intertrochanteric femur fractures. The primary outcome of the study is 30-day mortality, while the secondary outcome is intensive care unit (ICU) length of stay. Various inflammatory biomarkers derived from routine laboratory parameters, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), immune-inflammatory prognostic index (IPI), aggregate index of systemic inflammation (AIS), and RDW-to-albumin ratio (RAR), will be analyzed to investigate their prognostic value in the acute postoperative period. The study seeks to identify simple and readily accessible biomarkers that may contribute to early risk stratification and perioperative management in elderly hip fracture patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-22.
Trial Details
NCT Number NCT07607886
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Intertrochanteric Femur Fracture, Hip Fracture Surgeries, Geriatric Anesthesia
Enrollment 233 participants
Start Date 2021-01-01
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-28